Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer

Completed · Phase 1

Conditions studied: Non-melanomatous Skin Cancer

In brief

RATIONALE: Biological therapies, such as imiquimod cream, work in different ways to stimulate the immune system and stop tumor cells from growing. PURPOSE: This randomized phase I trial is studying how well imiquimod cream works in treating patients with basal cell skin cancer.

Key facts

Study ID

NCT00079300

Run by

National Naval Medical Center

Starts

2004-01-01

Expected to finish

2005-08-01

Last updated by the study team

2013-04-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• NIH - Warren Grant Magnuson Clinical Center — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.